|
[1]ZHAO K, ZHANG YX.Treatment of minimal hepatic encephalopathy[J].J Clin Hepatol, 2014, 30 (4) :108-110. (in Chinese) 赵凯, 张跃新.轻微肝性脑病的治疗现状[J].临床肝胆病杂志, 2014, 30 (4) :108-110.
|
|
[2]VILSTRUP H, AMODIO P, BAJAJ J, et al.Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the American Association for the Study of Liver Diseases and the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology, 2014, 60 (2) :715-735.
|
|
[3]MENDOZA G, MARTIFABREGAS J, KULISEVSKY J, et al.Hepatic myelopathy:a rare complication of portocaval shunt[J].Eur Neurol, 1994, 34 (4) :209-212.
|
|
[4]BEZERRA ML, HARUMI JA, SHINOSAKI JS, et al.Hepatitis C virus:a rare manifestation-remitting relapsing central and peripheral demyelination[J].Neurol India, 2011, 59 (1) :114-116.
|
|
[5]XU CL, WANG DX.Peripheral neuropathy associated with viral hepatitis[J].China J Contempt Neuron Neurosurg, 2012, 12 (4) :480-482. (in Chinese) 许春伶, 王得新.病毒性肝炎伴发周围神经病变[J].中国现代神经疾病杂志, 2012, 12 (4) :480-482.
|
|
[6]CHENG DY, WANG XM, OU WN, et al.Clinical analysis literature review on 7 cases with liver diseases complicated by GuillainBarre syndrome and related literature review[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2014, 8 (3) :387-390. (in Chinese) 程丹颖, 王笑梅, 欧蔚妮, 等.肝病合并格林-巴利综合征七例临床分析及文献复习[J/CD].中华实验和临床感染病杂志:电子版, 2014, 8 (3) :387-390.
|
|
[7]PERMKUMAR M, BAGCHI A, KAPOOR N, et al.Hepatic myelopathy in and a patient with decompensated alcoholic cirrhosis and portal colopathy[J].Case Reports Hepatol, 2012, 2012:735906.
|
|
[8]SUREKA B, BANSAL K, PATIDAR Y, et al.Neurologic manifestations of chronic liver disease and liver cirrhosis[J].Curr Prob Diagn Radiol, 2015, 44 (5) :449-461.
|
|
[9]CASH WJ, Mc CONVILLE P, Mc DERMOTT E, et al.Current concepts in the assessment and treatment of hepatic encephalopathy[J].QJM, 2010, 103 (1) :9-16.
|
|
[10]FERRO JM, VIANA P, SANTOS P.Management of neurologic manifestations in patients with liver disease[J].Curr Treat Options Neurol, 2016, 18 (8) :37.
|
|
[11]ABID S, JAFRIW, MUMTAZ K, et al.Efficacy of L-omithineL-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy[J].J Coll Physicians Surg Pak, 2011, 21 (11) :666-671.
|
|
[12]KHAN AA, SHAIK MV, PARVEEN N, et al, Human fetal liver derived stem cell transplantation as supportive modality management of end stage decompensated liver cirrhosis[J].Cell Transplant, 2010, 47 (1) :1.
|
|
[13]RUGGERO MA, ARGENTO AC, HEAVNER MS, et al.Molecular Adsorbent Recalculating System (MARS) removal of piperaoillin/tazobactam in a patient with acetaminophen-induced acute liver failure[J].Transpl Infect Dis, 2013, 15 (2) :214-218.
|
|
[14]GARCOVICH M, ZOCCO MA, ROCCARINA D, et al.Prevention and treatment of hepatic encephalopathy:focusing on gut microbiota[J].World J Gastroenterology, 2012, 18 (46) :6693-6700.
|
|
[15]BAJAJ JS, HEUMAN DM, HYLEMON PB, et al.Randomized clinical trial:lactobacillus GG modulates gut micro biome, metabolome and end toxemia in patients with cirrhosis[J].Aliment Pharmacol Ther, 2014, 39 (10) :1113-1125.
|
|
[16]BUTTERWORTH R.Metal toxicity liver disease and neurodegeneration[J].Neurotox Res, 2010, 18 (1) :100-105.
|
|
[17]NARDONE R, HOLLER Y, THOMSCHEWSKI A, et al.Central motor conduction studies in patients with spinal cord disorders:a review[J].Spinal Cord, 2014, 52 (6) :420-427.
|
|
[18]YANG Y, YANG L.Research progress in hepatic myelopathy[J].J Clin Hepatol, 2015, 31 (12) :2097-2099. (in Chinese) 杨阳, 杨龙.肝性脊髓病研究进展[J].临床肝胆病杂志, 2015, 31 (12) :2097-2099.
|
|
[19]PAN YP, FAN N, LI M.Advances in research of hepatic myelopathy[J].Chin J Disaster Med, 2014, 2 (12) :710-712. (in Chinese) 潘宜鹏, 范宁, 李明.肝性脊髓病研究现状[J].中华灾害救援医学, 2014, 2 (12) :710-712.
|
|
[20]QI HY, XIAO ZY, WANG YX, et al.Clinical analysis and discuss of the possible pathogenesis of hepatic myelopathy[J].Occup Health, 2008, 24 (1) :1979-1980. (in Chinese) 歧红阳, 肖占宇, 王云溪, 等.肝性脊髓病的临床分析及可能发病机制[J].职业与健康, 2008, 24 (1) :1979-1980.
|
|
[21]SCHREIBER AL, NORBURY JW, de SOUSA EA.Functional recovery of untreated human immunodeficiency virus-associated Guillain-Barre syndrome:a case report[J].Ann Phys Rehabil Med, 2011, 54 (8) :519-524.
|
|
[22]MALAGUARNERA M, GARGANTE MP, MALAGUARNERA G, et al.Bifid bacterium combined with fructo-oligosaccharide versus lacunose in the treatment of patients with hepatic encephalopathy[J].Eur J Gastroenterol Heaton, 2010, 22 (2) :199-206.
|
|
[23]ZHAO YL.The analysis of clinical therapeutic efficacy on 29 cases of hepatic myelopathy[J].Chin Prac Med, 2011, 6 (6) :100-101. (in Chinese) 赵宇亮.肝性脊髓病29例临床疗效分析[J].中国实用医药, 2011, 6 (6) :100-101.
|
|
[24]CHIN RL, SANDER HW, BRANNAGAN TH, et al.Demyelinating neuropathy in patients with hepatitis C Virus infection[J].J Clin Neuromuscular Dis, 2010, 11 (4) :209-212.
|
DownLoad: